Literature DB >> 12654854

Expression of Helicobacter pylori vacuolating toxin in Escherichia coli.

Mark S McClain1, Timothy L Cover.   

Abstract

VacA is a secreted toxin that plays a role in Helicobacter pylori colonization of the stomach and that contributes to the pathogenesis of peptic ulcer disease. Studies of VacA structure and function have been hindered by the lack of an efficient system for expression and genetic manipulation of this toxin. In this study, we developed methodology for expression of a functionally active VacA toxin in Escherichia coli. We then used a high-throughput screen to analyze a library of mutant toxins with pentapeptide insertions and identified six mutants that lacked the capacity to induce vacuolation of HeLa cells. The capacity to analyze VacA in this heterologous-expression system should greatly facilitate efforts to elucidate the structure and function of this toxin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654854      PMCID: PMC152094          DOI: 10.1128/IAI.71.4.2266-2271.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Pentapeptide scanning mutagenesis: encouraging old proteins to execute unusual tricks.

Authors:  F Hayes; B Hallet
Journal:  Trends Microbiol       Date:  2000-12       Impact factor: 17.079

2.  Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin.

Authors:  V Q Nguyen; R M Caprioli; T L Cover
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Functional complementation reveals the importance of intermolecular monomer interactions for Helicobacter pylori VacA vacuolating activity.

Authors:  Dan Ye; Steven R Blanke
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

4.  In search of the Helicobacter pylori VacA mechanism of action.

Authors:  E Papini; M Zoratti; T L Cover
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

5.  Two distinctive cell binding patterns by vacuolating toxin fused with glutathione S-transferase: one high-affinity m1-specific binding and the other lower-affinity binding for variant m forms.

Authors:  W C Wang; H J Wang; C H Kuo
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

Review 6.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

7.  Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS.

Authors:  D Kuck; B Kolmerer; C Iking-Konert; P H Krammer; W Stremmel; J Rudi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin.

Authors:  T L Cover; W Puryear; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

9.  A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.

Authors:  M S McClain; P Cao; H Iwamoto; A D Vinion-Dubiel; G Szabo; Z Shao; T L Cover
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  9 in total

1.  Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

2.  Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.

Authors:  Mark S McClain; Daniel M Czajkowsky; Victor J Torres; Gabor Szabo; Zhifeng Shao; Timothy L Cover
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

3.  Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2.

Authors:  Chandrabali Ghose; Guillermo I Perez-Perez; Victor J Torres; Marialuisa Crosatti; Abraham Nomura; Richard M Peek; Timothy L Cover; Fritz Francois; Martin J Blaser
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

4.  Construction and preservation of a stable and highly expressed recombinant Helicobacter pylori vacuolating cytotoxin A with apoptotic activity.

Authors:  Ling-Zhi Yuan; Xiao Shi; Dan Tang; Shao-Peng Zheng; Zhi-Ming Xiao; Fen Wang
Journal:  BMC Microbiol       Date:  2021-08-18       Impact factor: 3.605

5.  Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.

Authors:  Susan E Ivie; Mark S McClain; Holly M Scott Algood; D Borden Lacy; Timothy L Cover
Journal:  BMC Microbiol       Date:  2010-02-23       Impact factor: 3.605

6.  Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.

Authors:  Susan E Ivie; Mark S McClain; Victor J Torres; Holly M Scott Algood; D Borden Lacy; Rong Yang; Steven R Blanke; Timothy L Cover
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

7.  Membrane channel structure of Helicobacter pylori vacuolating toxin: role of multiple GXXXG motifs in cylindrical channels.

Authors:  Sanguk Kim; Aaron K Chamberlain; James U Bowie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

8.  The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay.

Authors:  Christian González-Rivera; Holly M Scott Algood; Jana N Radin; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

9.  Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin.

Authors:  Teal M Pelish; Mark S McClain
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.